SYRE Spyre Therapeutics, Inc. - Common Stock
$105,64
Harga · Agu 19, 2026
Fundamental per Agu 4, 2026
Rentang 52M
$15–$110
95% of range
Peringkat Analis
STRONG BUY
23 analysts
Target Harga
$125
+18% upside
P/E (TTM)
33.0
ROE
-26.5%
Margin Laba Bersih
—
Tentang Spyre Therapeutics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
SYRE Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$105.64
Kapitalisasi Pasar
$8.33B
P/E (TTM)
33.0
EPS (TTM)
$13.76
Pendapatan (TTM)
$0
Imbal Hasil Dividen
—
ROE
-26.5%
D/E Utang/Ekuitas
—
Rentang 52M
$15 – $110
SYRE Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$0
2016-12-31
→
2025-12-31
EPS
$13.76
2020-12-31
→
2023-12-31
Arus Kas Bebas
—
2016-12-31
→
2024-12-31
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
SYRE
Median Rekan
P/E (TTM)
33.0
16.0
P/B
11.6
3.9
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
SYRE
Median Rekan
ROA
-22.4%
-22.2%
ROE
-26.5%
-37.6%
ROIC
-29.3%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
SYRE
Median Rekan
Current Ratio (Rasio Lancar)
13.3
5.7
Quick Ratio (Rasio Cepat)
1.5
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
SYRE
Median Rekan
Revenue YoY (Pendapatan YoY)
-62.0%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
SYRE
Median Rekan
SYRE Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
23 analis
- Beli Kuat 11 47,8%
- Beli 10 43,5%
- Tahan 2 8,7%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
14 analis · 2026-08-19
Median
$126.50
Sekarang
$105.64
Rendah
$97.00
Tinggi
$140.00
Target median
$126.50
+19,7%
Target rata-rata
$124.71
+18,1%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.22%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $-0.36 | $-0.77 | 0.41% |
| 31 Maret 2026 | $-0.74 | $-0.68 | -0.06% |
| 31 Des. 2025 | $-0.70 | $-0.79 | 0.09% |
| 30 Sep. 2025 | $-0.15 | $-0.76 | 0.61% |
| 30 Juni 2025 | $-0.77 | $-0.77 | -0.00% |
| 31 Maret 2025 | $-0.60 | $-0.86 | 0.26% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | — |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $886.0K | $2M | $19M | $0 | $0 | $4M | $5M | $5M | |
| R&D Expense | · | · | · | $59M | $57M | $60M | $65M | $37M | $23M | $18M | |
| SG&A Expense | $48M | $46M | $40M | $29M | $27M | $22M | $16M | $13M | $10M | $8M | |
| Operating Expenses | $210M | $209M | $243M | $87M | $84M | $81M | $80M | $49M | $33M | $27M | |
| Operating Income | $-210M | $-209M | $-242M | $-85M | $-66M | $-81M | $-80M | $-45M | $-28M | $-22M | |
| Other Non-op | $29M | $-21M | $-19M | $-7.0K | $-122.0K | $-5.0K | $-63.0K | $-57.0K | $-42.0K | $-36.0K | |
| Pretax Income | $-155M | $-208M | $-339M | $-84M | $-66M | $-81M | $-78M | · | · | · | |
| Income Tax | $-15.0K | $51.0K | $-26.0K | $-136.0K | $141.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-155M | $-208M | $-339M | $-84M | $-66M | $-81M | $-78M | $-44M | $-27M | $-22M | |
| EPS (Basic) | · | · | $13.76 | $-24.86 | $-25.02 | $-1.52 | · | · | · | · | |
| EPS (Diluted) | · | · | $13.76 | $-24.86 | $-25.02 | $-1.52 | · | · | · | · | |
| Shares (Basic) | · | · | 6,897,065 | 3,371,231 | 2,629,784 | 53,371,730 | · | · | · | · | |
| Shares (Diluted) | · | · | 6,897,065 | 3,371,231 | 2,629,784 | 53,371,730 | · | · | · | · | |
| EBITDA | $-210M | $-209M | $-242M | $-83M | $-64M | $-80M | $-80M | $-45M | $-27M | $-22M |
Neraca 21
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $86M | $89M | $189M | $35M | $15M | $90M | $19M | $22M | $13M | $48M | |
| Short-term Investments | · | · | · | · | · | · | · | $52M | $37M | $16M | |
| Prepaid Expense | $21M | $5M | $2M | $6M | $5M | $4M | $3M | $2M | $2M | $2M | |
| Current Assets | $778M | $608M | $342M | $62M | $99M | $150M | $75M | $77M | $55M | $66M | |
| PP&E (Net) | · | · | $0 | $3M | $5M | $6M | $2M | $1M | $854.0K | $599.0K | |
| PP&E (Gross) | · | · | $0 | $7M | $7M | $8M | $3M | $2M | $1M | $839.0K | |
| Accum. Depreciation | · | · | $0 | $4M | $3M | $2M | $1M | $752.0K | $487.0K | $240.0K | |
| Other Non-current Assets | $0 | $10.0K | $9.0K | $683.0K | $842.0K | $115.0K | $67.0K | $50.0K | $232.0K | $40.0K | |
| Total Assets | $778M | $608M | $342M | $71M | $110M | $162M | $83M | $78M | $56M | $67M | |
| Accounts Payable | · | · | · | $677.0K | $3M | $2M | $3M | $663.0K | $389.0K | $168.0K | |
| Current Liabilities | $59M | $54M | $32M | $15M | $20M | $16M | $18M | $10M | $6M | $4M | |
| Capital Leases | · | · | $0 | $4M | $5M | $5M | $5M | · | · | · | |
| Other Non-current Liabilities | $0 | · | · | $0 | $16.0K | $214.0K | $31.0K | $72.0K | $111.0K | $132.0K | |
| Total Liabilities | $63M | $91M | $73M | $21M | $26M | $22M | $23M | $10M | $6M | $4M | |
| Common Stock | $15.0K | $13.0K | $10.0K | $6.0K | $5.0K | $5.0K | $3.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | $184M | $123M | $108M | |
| Retained Earnings | $-1.13B | $-972M | $-764M | $-426M | $-342M | $-276M | $-195M | $-117M | $-73M | $-45M | |
| AOCI | $869.0K | $180.0K | $302.0K | $-48.0K | $-20.0K | $11.0K | $51.0K | $-27.0K | $-102.0K | $-4.0K | |
| Stockholders' Equity | $715M | $518M | $184M | $50M | $84M | $140M | $60M | $67M | $50M | $63M | |
| Liabilities + Equity | $778M | $608M | $342M | $71M | $110M | $162M | $83M | $78M | $56M | $67M | |
| Shares Outstanding | 78,189,811 | 60,257,000 | 36,057,000 | 2,614,000 | 1,974,000 | 1,918,000 | 29,084,437 | 24,140,097 | 16,670,188 | 13,430,833 |
Arus Kas 12
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $0 | $744.0K | $2M | $2M | $996.0K | $418.0K | $293.0K | $249.0K | $132.0K | |
| Stock-based Comp | $38M | $45M | $26M | $7M | $8M | $6M | $5M | $4M | $2M | $1M | |
| Other Non-cash | $-52M | $6M | $212M | $-5M | $2M | $-2M | $7M | $8M | $-120.0K | $2M | |
| Operating Cash Flow | $-169M | $-157M | $-100M | $-80M | $-54M | $-76M | $-66M | $-32M | $-25M | $-19M | |
| CapEx | · | $0 | $0 | $38.0K | $573.0K | $4M | $1M | $422.0K | $619.0K | $212.0K | |
| Investing Cash Flow | $-143M | $-353M | $-108M | $57M | $-23M | $-8M | $-2M | $-15M | $-23M | $-12M | |
| Stock Issued | · | · | $85M | $0 | $0 | · | · | · | · | · | |
| Net Stock Activity | · | · | $85M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $309M | $411M | $361M | $43M | $1M | $155M | $66M | $57M | $12M | $49M | |
| Net Change in Cash | $-4M | $-100M | $153M | $19M | $-75M | $71M | $-2M | $10M | $-35M | $18M | |
| Taxes Paid | $-15.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-157M | $-100M | $-80M | $-54M | $-80M | $-67M | $-33M | $-25M | $-19M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -27348.0% | -3640.2% | -350.3% | · | · | -1169.3% | · | · | |
| Net Margin | · | · | -38238.2% | -3598.7% | -351.1% | · | · | -1140.6% | · | · | |
| Pretax Margin | · | · | -38241.1% | -3604.6% | -350.4% | · | · | · | · | · | |
| EBITDA Margin | · | · | -27264.0% | -3573.0% | -341.9% | · | · | -1161.8% | · | · | |
| ROA | -22.4% | -43.8% | · | -92.6% | -48.5% | -66.1% | -97.3% | -66.3% | -44.2% | -41.0% | |
| ROE | -26.5% | -49.2% | · | -142.2% | -70.8% | -58.6% | -111.9% | -67.7% | -48.1% | -106.5% | |
| ROIC | -29.3% | -40.3% | · | -168.3% | -78.4% | · | · | · | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.3 | 11.3 | · | 4.2 | 4.9 | 9.1 | 4.1 | 7.5 | 9.8 | 16.8 | |
| Quick Ratio | 1.5 | 1.7 | · | 2.4 | 0.8 | 5.5 | 1.0 | 7.3 | 8.9 | 16.0 |
Efisiensi 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | · | · |
Tingkat Pertumbuhan 1
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -62.0% | -87.6% | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $886.0K | $2M | $19M | $0 | $0 | $4M | $5M | $5M | |
| Net Income TTM | $-155M | $-208M | $-339M | $-84M | $-66M | $-81M | $-78M | $-44M | $-27M | $-22M | |
| Market Cap | $2.56B | $1.40B | · | $735M | $5.86B | $9.44B | $5.56B | $4.52B | $2.25B | $1.46B | |
| P/E | 10.1 | 7.2 | 1.6 | -0.5 | -4.7 | -129.4 | · | · | · | · | |
| P/S | · | · | · | 315.7 | 312.8 | · | · | 1162.6 | 433.2 | 315.6 | |
| P/B | 3.6 | 2.7 | · | 14.6 | 69.8 | 67.5 | 92.5 | 67.0 | 44.8 | 23.2 | |
| P / Tangible Book | 3.6 | 2.7 | 4.2 | 14.6 | 69.8 | 67.5 | · | · | · | · | |
| P / Cash Flow | -15.1 | -8.9 | · | -9.2 | -109.1 | -124.5 | -84.6 | -140.4 | -91.6 | -77.5 | |
| P / FCF | · | -8.9 | · | -9.2 | -108.0 | -117.9 | -82.7 | -138.6 | -89.3 | -76.7 | |
| Earnings Yield | 9.9% | 13.9% | 63.9% | -221.0% | -21.1% | -0.77% | · | · | · | · |
Laporan Laba Rugi 14
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $688.0K | $198.0K | $174.0K | $625.0K | $1M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $14M | $12M | $15M | $17M | |
| SG&A Expense | $16M | $15M | $13M | $12M | $12M | $12M | $11M | $11M | $12M | $13M | $9M | $12M | $5M | $7M | $8M | $9M | |
| Operating Expenses | $42M | $46M | $57M | $57M | $42M | $54M | $61M | $55M | $44M | $48M | $18M | $160M | $19M | $19M | $23M | $26M | |
| Operating Income | $-42M | $-46M | $-57M | $-57M | $-42M | $-54M | $-61M | $-55M | $-44M | $-48M | $-18M | $-159M | $-19M | $-19M | $-22M | $-24M | |
| Other Non-op | $-5M | $-30M | $-12M | $40M | $-656.0K | $2M | $-818.0K | $-19M | $-610.0K | $-483.0K | $2M | $-8.0K | $-72.0K | $24.0K | $5.0K | $-30.0K | |
| Pretax Income | $-36M | $-69M | $-63M | $-11M | $-37M | $-45M | $-56M | $-69M | $-39M | $-44M | $-40M | $-217M | $-18M | $-18M | $-22M | $-24M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $-15.0K | $1.0K | $18.0K | $0 | $32.0K | $3.0K | $7.0K | $-36.0K | $-209.0K | $9.0K | $0 | |
| Net Income | $-36M | $-69M | $-63M | $-11M | $-37M | $-45M | $-56M | $-69M | $-39M | $-44M | $-40M | $-217M | $-18M | $-18M | $-22M | $-24M | |
| EPS (Basic) | · | · | · | · | · | · | · | $1.06 | $0.59 | $0.72 | $0.86 | $40.14 | $-4.89 | $-4.84 | $-0.27 | $-0.37 | |
| EPS (Diluted) | $-0.35 | $-0.74 | · | $-0.15 | · | · | · | $1.06 | $0.59 | $0.72 | $0.86 | $40.14 | $-4.89 | $-4.84 | $-0.27 | $-0.37 | |
| Shares (Basic) | · | · | · | · | · | · | · | 50,889,433 | 45,316,264 | 36,512,662 | 4,293,812 | 3,822,605 | 3,770,506 | 3,767,918 | 82,209,032 | 65,996,161 | |
| Shares (Diluted) | · | · | · | · | · | · | · | 50,889,433 | 45,316,264 | 36,512,662 | 4,293,812 | 3,822,605 | 3,770,506 | 3,767,918 | 82,209,032 | 65,996,161 | |
| EBITDA | $-42M | $-46M | · | $-57M | $-42M | $-54M | · | $-55M | $-44M | $-48M | $-18M | $-159M | $-18M | $-19M | $-22M | $-24M |
Neraca 17
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $162M | $97M | $86M | $65M | $82M | $48M | $89M | $72M | $45M | $228M | $91M | $235M | $35M | $39M | $37M | $15M | |
| Prepaid Expense | $28M | $22M | $21M | $18M | $12M | $5M | $5M | $7M | $10M | $3M | $2M | $3M | $6M | $8M | $8M | $5M | |
| Current Assets | $1.17B | $764M | $778M | $505M | $539M | $570M | $608M | $421M | $436M | $487M | $206M | $240M | $44M | $82M | $97M | $73M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $3M | $4M | $4M | $4M | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $9.0K | $10.0K | $78.0K | $749.0K | $752.0K | $800.0K | |
| Total Assets | $1.17B | $764M | $778M | $505M | $539M | $570M | $608M | $421M | $436M | $488M | $207M | $244M | $52M | $92M | $107M | $83M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $4M | $2M | $3M | |
| Current Liabilities | $63M | $85M | $59M | $46M | $83M | $71M | $54M | $58M | $22M | $43M | $45M | $232M | $13M | $18M | $16M | $16M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $4M | $4M | $4M | $4M | |
| Other Non-current Liabilities | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $8.0K | |
| Total Liabilities | $72M | $93M | $63M | $50M | $83M | $87M | $91M | $94M | $62M | $82M | $66M | $254M | $19M | $24M | $23M | $22M | |
| Common Stock | $16.0K | $15.0K | $15.0K | $13.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $10.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | |
| Retained Earnings | $-1.23B | $-1.20B | $-1.13B | $-1.07B | $-1.05B | $-1.02B | $-972M | $-916M | $-847M | $-808M | $-701M | $-661M | $-444M | $-407M | $-389M | $-366M | |
| AOCI | $-2M | $-767.0K | $869.0K | $791.0K | $454.0K | $682.0K | $180.0K | $1M | $-553.0K | $-363.0K | $-132.0K | $11.0K | $-6.0K | $-184.0K | $-220.0K | $-153.0K | |
| Stockholders' Equity | $1.10B | $671M | $715M | $455M | $456M | $483M | $518M | $327M | $374M | $152M | $-245M | $-207M | $34M | $68M | $84M | $62M | |
| Liabilities + Equity | $1.17B | $764M | $778M | $505M | $539M | $570M | $608M | $421M | $436M | $488M | $207M | $244M | $52M | $92M | $107M | $83M | |
| Shares Outstanding | 88,064,133 | 78,839,858 | 78,189,811 | 60,471,793 | 60,372,927 | 60,275,561 | 60,257,023 | 51,395,608 | 50,783,384 | 36,629,680 | 4,048,687 | 81,001,676 | 65,395,159 | 61,511,078 | 61,172,510 | 49,419,873 |
Arus Kas 9
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $360.0K | $384.0K | $401.0K | $378.0K | $403.0K | |
| Stock-based Comp | $14M | $13M | $10M | $10M | $9M | $9M | $9M | $13M | $9M | $14M | $5M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | $-1M | · | · | $-4M | |
| Operating Cash Flow | $-70M | $-57M | $-45M | $-37M | $-47M | $-41M | $-37M | $-29M | $-62M | $-29M | $-35M | $-17M | $-18M | $-15M | $-21M | $-26M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.0K | $0 | $37.0K | |
| Investing Cash Flow | $-298M | $57M | $-247M | $25M | $79M | $-61.0K | $-171M | $43M | $-121M | $-105M | $-98M | $7M | $18M | $16M | $750.0K | $26M | |
| Financing Cash Flow | $433M | $12M | $313M | $-5M | $731.0K | $125.0K | $226M | $13M | $360.0K | $172M | $-13M | $210M | $10.0K | $-130.0K | $43M | $12.0K | |
| Net Change in Cash | $65M | $11M | $21M | $-17M | $33M | $-41M | $18M | $26M | $-182M | $39M | $-145M | $200M | $137.0K | $1M | $23M | $-515.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-26M |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | -23146.2% | -9498.0% | -10778.7% | -3587.7% | -1794.5% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | -31552.5% | -9304.0% | -10479.3% | -3571.7% | -1794.1% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | -31551.5% | -9322.2% | -10599.4% | -3570.2% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | -23146.2% | -9304.0% | -10778.7% | -3587.7% | -1764.9% | |
| ROA | -4.2% | -10.3% | · | -2.4% | -7.5% | -8.5% | · | -22.0% | · | · | -26.8% | -124.0% | -27.2% | -16.5% | -17.6% | -19.8% | |
| ROE | -4.7% | -12.0% | · | -2.9% | -8.8% | -14.1% | · | -168.4% | · | · | 45.1% | 352.4% | -38.7% | -21.5% | -22.0% | -26.4% | |
| ROIC | -3.8% | -6.8% | · | -12.5% | -9.2% | -11.1% | · | -16.9% | -11.8% | -31.4% | 7.5% | 76.8% | -55.8% | -27.5% | -26.7% | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.5 | 9.0 | · | 10.9 | 6.5 | 8.1 | · | 7.3 | 19.7 | 11.4 | 4.6 | 1.0 | 3.5 | 4.7 | 6.1 | 4.5 | |
| Quick Ratio | 2.6 | 1.1 | · | 1.4 | 1.0 | 0.7 | · | 1.2 | 2.0 | 5.3 | 2.0 | 1.0 | 2.8 | 2.2 | 2.4 | 0.9 |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $688.0K | $886.0K | $1M | $2M | $2M | $4M | $17M | $16M | |
| Net Income TTM | $-153M | $-162M | · | $-162M | $-189M | $-196M | · | $-192M | $-340M | $-319M | $-294M | $-276M | $-83M | $-85M | $-74M | $-70M | |
| Market Cap | $7.82B | $3.98B | · | $1.01B | $904M | $973M | · | $1.51B | $1.19B | $1.39B | $50M | $913M | $474M | $809M | $772M | $2.84B | |
| P/E | · | · | · | 5.2 | 4.6 | 5.0 | · | 9.1 | 0.6 | 1.0 | 0.4 | 0.4 | -0.7 | -2.3 | -12.0 | · | |
| P/S | · | · | · | · | · | · | · | · | 1735.3 | 1568.1 | 46.8 | 542.0 | 201.0 | 227.2 | 45.2 | 172.7 | |
| P/B | 7.1 | 5.9 | · | 2.2 | 2.0 | 2.0 | · | 4.6 | 3.2 | 9.1 | -0.2 | -4.4 | 14.1 | 12.0 | 9.2 | 46.1 | |
| P / Tangible Book | 7.1 | 5.9 | · | 2.2 | 2.0 | 2.0 | · | 4.6 | 3.2 | 9.1 | · | · | 14.1 | 12.0 | 9.2 | 46.1 | |
| P / Cash Flow | · | -69.3 | · | · | · | -23.7 | · | · | · | -48.7 | · | · | -26.9 | · | · | -108.2 | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -108.0 | |
| Earnings Yield | · | · | · | 19.3% | 21.6% | 20.0% | · | 11.0% | 180.0% | 97.1% | 255.3% | 267.3% | -143.0% | -44.0% | -8.3% | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $0 | $0 | $886.0K | $2M | $19M |
| Margin Operasi % | — | — | -27348.0% | -3640.2% | -350.3% |
| Laba Bersih | $-155M | $-208M | $-339M | $-84M | $-66M |
| EPS Dilusian | — | — | $13.76 | $-24.86 | $-25.02 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 13.3 | 11.3 | — | 4.2 | 4.9 |
| Rasio Cepat | 1.5 | 1.7 | — | 2.4 | 0.8 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | — | $-157M | $-100M | $-80M | $-54M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 278 pengaju · $6.3B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 100 (+40 vs Kuartal sebelumnya) | 21 (+10 vs Kuartal sebelumnya) | 90 (+27 vs Kuartal sebelumnya) | 60 (+11 vs Kuartal sebelumnya) | +9.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $809.889.779 | 9.122.435 | 12,77% | Saham |
| PERCEPTIVE ADVISORS LLC | $383.484.855 | 4.319.496 | 6,04% | Saham |
| RTW INVESTMENTS, LP | $377.492.205 | 4.251.996 | 5,95% | Saham |
| Paradigm Biocapital Advisors LP | $340.984.271 | 3.840.778 | 5,37% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $306.173.899 | 3.448.681 | 4,83% | Saham |
| STATE STREET CORP | $271.437.392 | 3.057.416 | 4,28% | Saham |
| Venrock Adviser, LLC | $265.048.073 | 2.985.448 | 4,18% | Saham |
| Driehaus Capital Management LLC | $248.509.957 | 2.799.166 | 3,92% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $214.266.641 | 2.280.766 | 3,38% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $206.866.100 | 2.330.098 | 3,26% | Saham |
| Capital World Investors | $205.574.795 | 2.315.553 | 3,24% | Saham |
| TCG Crossover Management, LLC | $168.733.670 | 1.900.582 | 2,66% | Saham |
| TANG CAPITAL MANAGEMENT LLC | $167.989.516 | 1.892.200 | 2,65% | Saham |
| BANK OF AMERICA CORP /DE/ | $153.183.764 | 1.725.431 | 2,41% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $152.905.794 | 1.722.300 | 2,41% | Saham |
| Remedium Capital Partners, LLC | $129.988.924 | 1.464.169 | 2,05% | Saham |
| Affinity Asset Advisors, LLC | $113.561.517 | 1.279.134 | 1,79% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $93.139.364 | 1.049.103 | 1,47% | Saham |
| Holocene Advisors, LP | $90.126.793 | 1.015.170 | 1,42% | Saham |
| Polar Capital Holdings Plc | $87.715.439 | 988.009 | 1,38% | Saham |
| Siren, L.L.C. | $85.992.130 | 968.598 | 1,36% | Saham |
| Capital International Investors | $84.802.301 | 955.196 | 1,34% | Saham |
| BRAIDWELL LP | $78.079.080 | 879.467 | 1,23% | Saham |
| Commodore Capital LP | $75.177.661 | 846.786 | 1,18% | Saham |
| GOLDMAN SACHS GROUP INC | $72.714.194 | 819.038 | 1,15% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $57.969.611 | 652.958 | 0,91% | Saham |
| Pictet Asset Management Holding SA | $55.766.092 | 628.138 | 0,88% | Saham |
| EMERALD ADVISERS, LLC | $50.376.435 | 567.430 | 0,79% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $49.182.345 | 553.980 | 0,78% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $48.952.315 | 551.389 | 0,77% | Saham |
| Candriam S.C.A. | $48.454.915 | 546.312 | 0,76% | Saham |
| EMERALD MUTUAL FUND ADVISERS TRUST | $35.624.839 | 401.271 | 0,56% | Saham |
| AMERIPRISE FINANCIAL INC | $30.737.766 | 346.224 | 0,48% | Saham |
| Integral Health Asset Management, LLC | $28.853.500 | 325.000 | 0,45% | Saham |
| Woodline Partners LP | $27.171.030 | 306.049 | 0,43% | Saham |
| JENNISON ASSOCIATES LLC | $26.916.321 | 303.180 | 0,42% | Saham |
| ADAR1 Capital Management, LLC | $25.211.922 | 283.982 | 0,40% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $23.075.964 | 259.923 | 0,36% | Saham |
| Cormorant Asset Management, LP | $19.975.500 | 225.000 | 0,31% | Saham |
| SEVEN GRAND MANAGERS, LLC | $19.975.500 | 225.000 | 0,31% | Saham |
| EVENTIDE ASSET MANAGEMENT, LLC | $17.901.699 | 201.616 | 0,28% | Saham |
| MILLENNIUM MANAGEMENT LLC | $17.464.091 | 196.712 | 0,28% | Saham |
| MARSHALL WACE, LLP | $17.267.533 | 194.498 | 0,27% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.903.712 | 190.400 | 0,27% | Opsi jual |
| ORBIMED ADVISORS LLC | $16.525.953 | 186.145 | 0,26% | Saham |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $16.240.614 | 182.931 | 0,26% | Saham |
| Caption Management, LLC | $15.421.086 | 173.700 | 0,24% | Opsi jual |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $15.352.104 | 172.923 | 0,24% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $13.778.656 | 155.200 | 0,22% | Opsi beli |
| SAMLYN CAPITAL, LLC | $13.557.239 | 152.706 | 0,21% | Saham |
| Balyasny Asset Management L.P. | $13.054.389 | 147.042 | 0,21% | Saham |
| Soleus Capital Management, L.P. | $13.050.660 | 147.000 | 0,21% | Saham |
| Squarepoint Ops LLC | $12.394.132 | 139.605 | 0,20% | Saham |
| ARMISTICE CAPITAL, LLC | $12.215.063 | 137.588 | 0,19% | Saham |
| Ensign Peak Advisors, Inc | $11.241.324 | 126.620 | 0,18% | Saham |
| NEUBERGER BERMAN GROUP LLC | $10.734.656 | 120.913 | 0,17% | Saham |
| Blackstone Inc. | $10.669.314 | 120.177 | 0,17% | Saham |
| Rhenman & Partners Asset Management AB | $10.591.454 | 119.300 | 0,17% | Saham |
| TD Asset Management Inc | $10.297.592 | 115.990 | 0,16% | Saham |
| Swiss National Bank | $9.987.750 | 112.500 | 0,16% | Saham |
| STEMPOINT CAPITAL LP | $9.492.890 | 106.926 | 0,15% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $9.278.930 | 104.516 | 0,15% | Saham |
| Boxer Capital Management, LLC | $8.878.000 | 100.000 | 0,14% | Saham |
| RHUMBLINE ADVISERS | $8.413.043 | 94.763 | 0,13% | Saham |
| F/m Investments LLC | $8.222.626 | 92.618 | 0,13% | Saham |
| BARCLAYS PLC | $8.187.292 | 92.220 | 0,13% | Saham |
| FEDERATED HERMES, INC. | $7.630.641 | 85.950 | 0,12% | Saham |
| Granahan Investment Management, LLC | $7.367.941 | 82.991 | 0,12% | Saham |
| CITIGROUP INC | $6.950.941 | 78.294 | 0,11% | Saham |
| HighVista Strategies LLC | $6.907.706 | 77.807 | 0,11% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $6.758.821 | 76.130 | 0,11% | Saham |
| BlackRock, Inc. | $6.744.883 | 75.973 | 0,11% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $6.316.253 | 71.145 | 0,10% | Saham |
| PRUDENTIAL FINANCIAL INC | $6.247.449 | 70.370 | 0,10% | Saham |
| B Group, Inc. | $6.214.600 | 70.000 | 0,10% | Saham |
| Trexquant Investment LP | $5.948.881 | 67.007 | 0,09% | Saham |
| CITADEL ADVISORS LLC | $5.497.258 | 61.920 | 0,09% | Saham |
| Informed Momentum Co LLC | $5.361.691 | 60.393 | 0,08% | Saham |
| SILVERARC CAPITAL MANAGEMENT, LLC | $5.323.160 | 59.959 | 0,08% | Saham |
| Hudson Bay Capital Management LP | $5.183.598 | 58.387 | 0,08% | Saham |
| Atle Fund Management AB | $5.063.123 | 57.030 | 0,08% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $4.798.737 | 54.052 | 0,08% | Saham |
| Susquehanna Portfolio Strategies, LLC | $4.714.307 | 53.101 | 0,07% | Saham |
| ALLIANCEBERNSTEIN L.P. | $4.667.718 | 92.540 | 0,07% | Saham |
| ROYCE & ASSOCIATES LP | $4.597.827 | 51.789 | 0,07% | Saham |
| XTX Topco Ltd | $4.481.881 | 50.483 | 0,07% | Saham |
| Monashee Investment Management LLC | $4.439.000 | 50.000 | 0,07% | Saham |
| Cinctive Capital Management LP | $4.348.267 | 48.978 | 0,07% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $4.234.628 | 47.698 | 0,07% | Saham |
| PFM Health Sciences, LP | $4.103.145 | 46.217 | 0,06% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.997.763 | 45.030 | 0,06% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3.989.580 | 44.250 | 0,06% | Saham |
| CITADEL ADVISORS LLC | $3.888.564 | 43.800 | 0,06% | Opsi beli |
| MetLife Investment Management, LLC | $3.845.594 | 43.316 | 0,06% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $3.824.000 | 43.071 | 0,06% | Saham |
| Moody Aldrich Partners LLC | $3.769.421 | 42.458 | 0,06% | Saham |
| Rock Springs Capital Management LP | $3.751.310 | 42.254 | 0,06% | Saham |
| JANE STREET GROUP, LLC | $3.666.614 | 41.300 | 0,06% | Opsi beli |
| Maven Securities LTD | $3.551.200 | 40.000 | 0,06% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.490.031 | 39.311 | 0,06% | Saham |
Orang dalam perusahaan 35 orang dalam · 18 pejabat · 17 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jeff Marc Goldberg | President and CEO | 29 Nov. 2022 A | — | 0 | 0 | $0 |
| Anthony G. Quinn | President & CEO | 16 Maret 2022 P | 550.540 | 0 | 0 | $0 |
| David George Lowe | CEO and President | 20 Maret 2017 A | 5.658 | 0 | 0 | $0 |
| Jonathan Alspaugh | President and CFO | 22 Juni 2023 A | 165.372 | 0 | 0 | $0 |
| Charles N York II | Chief Financial Officer and VP | 20 Feb. 2018 A | 34.787 | 0 | 0 | $0 |
| Leslie Sloan | Chief Operating Officer | 23 Agu 2022 A | — | 0 | 0 | $0 |
| Sheldon Sloan | Chief Medical Officer | 1 Juli 2026 M | 0 | 0 | 3 | $-1.355.871 |
| Heidy King-Jones | Chief Legal Officer and Corporate Secretary | 1 Feb. 2024 A | — | 0 | 0 | $0 |
| Linda L Neuman | Chief Medical Officer | 23 Feb. 2023 A | — | 0 | 0 | $0 |
| James Paul Kastenmayer | General Counsel | 23 Feb. 2023 A | — | 0 | 0 | $0 |
| Jr. Michael Conick Hanley | Chief Business Officer | 23 Feb. 2023 A | 36.200 | 0 | 0 | $0 |
| Steven Weber | VP, Controller&Princ Acctg Off | 17 Feb. 2022 A | — | 0 | 0 | $0 |
| James Wooldridge | Chief Medical Officer | 20 Feb. 2018 A | — | 0 | 0 | $0 |
| Aaron Schuchart | Chief Business Officer | 20 Feb. 2018 A | — | 0 | 0 | $0 |
| Scott W Rowlinson | VP, Research | 22 Agu 2017 A | 11.204 | 0 | 0 | $0 |
| Joseph E Tyler | VP, Manufacturing | 22 Agu 2017 A | 42.428 | 0 | 0 | $0 |
| Henry Hebel | VP, Product Development | 20 Maret 2017 A | — | 0 | 0 | $0 |
| Sandra Rojas-Caro | Chief Medical Officer | 17 Mei 2016 A | — | 0 | 0 | $0 |
| Michael Thomas Henderson | Direktur | 22 Juni 2026 S | 68.606 | 0 | 1 | $-2.000.000 |
| Sandra Milligan | Direktur | 14 Mei 2024 A | — | 0 | 0 | $0 |
| Laurie Stelzer | Direktur | 14 Mei 2024 A | — | 0 | 0 | $0 |
| Mark C. Mckenna | Direktur | 1 Feb. 2024 A | — | 0 | 0 | $0 |
| Hunter C Smith | Direktur | 22 Juni 2023 A | — | 0 | 0 | $0 |
| Alison Frances Lawton | Direktur | 22 Juni 2023 A | — | 0 | 0 | $0 |
| Russell J. Cox | Direktur | 22 Juni 2023 A | 7.000 | 0 | 0 | $0 |
| Ivana Magovcevic-Liebisch | Direktur | 22 Juni 2023 A | — | 0 | 0 | $0 |
| Marcio Souza | Direktur | 25 Agu 2022 P | 90.000 | 0 | 0 | $0 |
| Armen Shanafelt | Direktur | 7 Juni 2022 A | 150.000 | 0 | 0 | $0 |
| Sandesh Mahatme | Direktur | 7 Juni 2022 A | — | 0 | 0 | $0 |
| Bryan V Lawlis | Direktur | 7 Juni 2022 A | — | 0 | 0 | $0 |
| Suzanne Louise Bruhn | Direktur | 8 Juni 2020 A | — | 0 | 0 | $0 |
| George Georgiou | Direktur | 7 Juni 2018 A | — | 0 | 0 | $0 |
| Jeffrey W. Albers | — | 7 Agu 2026 M | 9.360 | 0 | 3 | $-2.404.190 |
| Scott L Burrows | — | 3 Agu 2026 M | 97.994 | 0 | 10 | $-3.214.747 |
| Cameron Turtle | — | 3 Agu 2026 S | 567.540 | 0 | 11 | $-3.804.537 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 2 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Peter Evan Harwin, Tomas Kiselak ×8 pengajuan | 23 Juni 2026 | 9,99% | Amandemen | Kampanye dewan | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker, Julian C. Baker ×3 pengajuan | 10 Feb. 2022 | — | Pengajuan awal | Kampanye dewan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 52 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 6,41% | 91.588 NS | 31 Mei 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 3,68% | 80.958 NS | 31 Mei 2026 | N-PORT |
| BBC · ETFis Series Trust I | 1,64% | 8.208 NS | 30 April 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,89% | 1.327 NS | 30 April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,88% | 61.270 NS | 30 April 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,80% | 5.695 NS | 31 Mei 2026 | N-PORT |
| ESSC · Strategy Shares | 0,44% | 1.513 NS | 30 April 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 0,35% | 960 NS | 31 Mei 2026 | N-PORT |
| GSC · Goldman Sachs ETF Trust | 0,33% | 11.214 NS | 31 Mei 2026 | N-PORT |
| BIB · ProShares Trust | 0,29% | 2.905 NS | 31 Mei 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 24.522 NS | 30 April 2026 | N-PORT |
| RSSL · Global X Funds | 0,17% | 32.342 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,14% | 3.514 NS | 31 Mei 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,12% | 360.437 NS | 31 Mei 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,09% | 12.695 NS | 31 Mei 2026 | N-PORT |
| UWM · ProShares Trust | 0,08% | 2.748 NS | 31 Mei 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 22.417 NS | 30 April 2026 | N-PORT |
| URTY · ProShares Trust | 0,06% | 2.782 NS | 31 Mei 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 0,05% | 300 NS | 31 Mei 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 75 NS | 31 Mei 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,03% | 2.863 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 70 NS | 31 Mei 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,02% | 24.878 NS | 31 Mei 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4.004 NS | 30 April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 44.082 NS | 31 Mei 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 870 NS | 31 Mei 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,00% | 45 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | — | — | 30 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| ITOT · iShares Trust | — | — | 22 Juli 2026 | Harian |
| IWV · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWO · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWM · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IBB · iShares Trust | — | — | 18 Agu 2026 | Harian |
| PTH · Invesco Exchange-Traded Fund Trust | — | — | 13 Juli 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 23 Juli 2026 | Harian |
| VHT · VANGUARD WORLD FUND | — | — | 20 Juli 2026 | Harian |
| ISCB · iShares Trust | — | — | 20 Juli 2026 | Harian |
| ISCG · iShares Trust | — | — | 21 Juli 2026 | Harian |
| ISCV · iShares Trust | — | — | 20 Juli 2026 | Harian |
| SMLF · iShares Trust | — | — | 10 Agu 2026 | Harian |
| SMMV · iShares Trust | — | — | 18 Agu 2026 | Harian |
| ESML · iShares Trust | — | — | 14 Agu 2026 | Harian |
| WSML · iShares Trust | — | — | 20 Juli 2026 | Harian |